Taipei, Taipei Medical University (TMU) Hospital on Tuesday celebrated the completion of its Taipei Cancer Center, which is slated to become operational in April next year.
Addressing the completion ceremony, TMU President Lin Chien-huang (林建煌) said the center is a milestone in the hospital’s pursuit of cancer translational medicine.
To make the center into a world top-tier facility, its management system, as well as the software and hardware used, are modeled upon those at the Dana-Faber Cancer Institute, which is affiliated with Harvard Medical School in the United States.
Taipei Cancer Center Superintendent Chiou Jeng-fong (邱仲峯) said the building’s second floor will be used exclusively for treating children suffering from cancer, including leukemia, brain cancer, lymphoma and solid tumors.
Taiwan sees an increase of around 700 cases of cancer among children per year among those aged from birth to the age of 19, Chiou said.
Among the different types of cancer most commonly suffered by children, osteosarcoma is the hardest to treat and will be one of the areas which the Taipei Cancer Center will focus heavily upon, given that half of the children who contract cancer can be cured and over 80 percent of them can achieve a two-year survival rate.
To meet that goal, the center has recruited James S. Miser, former chief executive officer and chief medical officer of the U.S- based City of Hope National Medical Center, who will share his expertise with the staff in Taipei, Chiou explained.
Cancer has been the top cause of death in Taiwan for 37 consecutive years, with around 50,000 patients dying from the condition in 2019, Ministry of Health and Welfare statistics show.
In order to provide the best possible care for cancer patients, the Taipei Cancer Center will also open a clinical research center, equipped with 20 beds, as part of its efforts to develop the most advanced medicines and technologies for cancer treatment.
Source: Focus Taiwan News Channel